Literature DB >> 6745290

Sensitivity and specificity of two-dimensional echocardiography in detection of impaired left ventricular function.

R Erbel, P Schweizer, W Krebs, J Meyer, S Effert.   

Abstract

The purpose of the study was to determine the sensitivity and specificity of two-dimensional echocardiography (2dE) in the detection of impaired left ventricular function, compared with cineventriculography (CVG). Apical two-dimensional echocardiograms were performed in 110 patients undergoing heart catheterization for the evaluation of clinically suspected coronary heart disease (50 patients), valvular heart disease (38 patients) and congestive cardiomyopathy (22 patients). The left ventricle was scanned in the RAO-equivalent view; cineventriculograms were filmed in the 30 degrees RAO projection. Left ventricular volumes at end-diastole (EDV) and end-systole (ESV) were determined using a disc method; stroke volume (SV) and ejection fraction (EF) were calculated. Based on normal values, the sensitivity, specificity, and predictive accuracy were determined for two-dimensional echocardiography. For EDV, the sensitivity was 80%, specificity 88% and (+) predictive accuracy 86%. The left ventricular ejection fraction was 57.8 +/- 17.2% with CVG and 53.8 +/- 15.6% with 2dE in patients with coronary heart disease, 24.9 +/- 10.5% with CVG and 25.2 +/- 11.1% with 2dE in patients with congestive cardiomyopathy, and 61.1 +/- 13.9% with CVG and 54.2 +/- 9.1% with 2dE in patients with valvular heart disease. Sensitivity was 81%, specificity 100%, and (+) predictive accuracy 100%. The study demonstrates that impaired left ventricular function can be detected by 2dE with high sensitivity and specificity. Thus, 2dE seems to be suitable screening method for evaluation of left ventricular function.

Entities:  

Mesh:

Year:  1984        PMID: 6745290     DOI: 10.1093/oxfordjournals.eurheartj.a061694

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

2.  Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.

Authors:  F Lennie Wong; Smita Bhatia; Wendy Landier; Liton Francisco; Wendy Leisenring; Melissa M Hudson; Gregory T Armstrong; Ann Mertens; Marilyn Stovall; Leslie L Robison; Gary H Lyman; Steven E Lipshultz; Saro H Armenian
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

3.  Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease.

Authors:  Alessia Gimelli; Patrizia Landi; Paolo Marraccini; Rosa Sicari; Paolo Frumento; Antonio L'Abbate; Daniele Rovai
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-09       Impact factor: 2.357

4.  [Percutaneous transfemoral valvuloplasty in patients with calcified aortic stenosis and significantly increased surgical risk: clinical course and value of Doppler sonography in assessment of therapeutic success].

Authors:  H Kücherer; H Katus; R Dietz; B Rauch; W Kübler
Journal:  Klin Wochenschr       Date:  1988-07-01

5.  Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review.

Authors:  Abdosaleh Jafari; Aziz Rezapour; Marjan Hajahmadi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

6.  Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients.

Authors:  Alain Mina; Hind Rafei; Maya Khalil; Yasmine Hassoun; Zeina Nasser; Arafat Tfayli
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.